M. Marazuela et al., UP-REGULATED BETA(1)-INTEGRIN EXPRESSION IN AUTOIMMUNE THYROID-DISORDERS, Clinical and experimental immunology, 109(1), 1997, pp. 107-115
Lymphocytic infiltration of the thyroid gland in autoimmune thyroid di
sorders requires, as a first step, their attachment to endothelial cel
ls (EC) and, subsequently, interaction with thyrocytes and extracellul
ar matrix proteins. Recent studies have focused on the pathophysiologi
c role of beta(1)-integrins as adhesion receptors for extracellular ma
trix proteins and as cell-to-cell adhesion receptors. In this study, w
e examine by flow cytometry and immunohistochemical techniques the dif
ferences in expression of beta(1)-integrins in thyrocytes and EC betwe
en normal thyroids and thyroid glands from patients with Graves' disea
se (GD) and Hashimoto's thyroiditis (HT). Remarkably, we found an up-r
egulated de novo expression of very late antigen (VLA)-alpha 6 subunit
in thyrocytes in close proximity to lymphocyte infiltrates in GD and
HT thyroid glands, with no reactivity in control thyroids. Moreover, i
nterferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha)
and IL-1 beta produced a significant enhancement of VLA-alpha 6 expres
sion in vitro in thyrocytes in culture. In addition, an up-regulated e
xpression of VLA-alpha 5 and beta 1 subunits was found in thyrocytes f
rom GD and HT glands, specifically in those areas more severely inflam
ed. VLA-alpha 2 was basally expressed in middle size and large vessels
in control glands, with an increased expression in vessels of all siz
es in HT and GD glands. Dendritic cells in thyroid lymphoid follicles
were also positive for VLA-beta 1, alpha 2 and alpha 6 subunits. These
results indicate the existence of an up-regulatory process in the exp
ression of beta(1)-integrins, particularly the alpha 6 subunit, in sev
eral cell types from inflamed GD and HT thyroid glands, suggesting tha
t these integrins could play a relevant role in localizing and perpetu
ating the autoimmune response in the thyroid gland in autoimmune thyro
id disorders.